Evogene Ltd Company Profile (NYSE:EVGN)

About Evogene Ltd (NYSE:EVGN)

Evogene Ltd logoEvogene Ltd. (Evogene) is a biotechnology company for the improvement of crop productivity. The Company is engaged in developing seed traits for improved yield and abiotic stress tolerance, seed traits for biotic stress resistance, herbicides and bio-stimulants. The Company operates a seed business under its subsidiary Evofuel Ltd. (Evofuel). It operates through two segments. Its Evogene segment develops seed traits, ag-chemical products, and ag-biological products to improve plant performance. The Company's Evofuel segment develops species of the castor bean plant for second generation feedstock for biofuel and other industrial uses. Its Crop Enhancement (CE) division is developing two types of products: CE seed traits, are seed traits having improved yield and abiotic stress tolerance, and ag-biologicals, which focuses on microbial-based bio-stimulants. The Company's Crop Protection (CP) division is developing two types of products: CP seed traits and ag-chemicals.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Symbol: NYSE:EVGN
  • CUSIP: N/A
  • Web: www.evogene.com
Capitalization:
  • Market Cap: $135.94 million
  • Outstanding Shares: 25,626,000
Average Prices:
  • 50 Day Moving Avg: $5.20
  • 200 Day Moving Avg: $5.28
  • 52 Week Range: $4.86 - $7.09
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -35.37
  • P/E Growth: 0.0000
Sales & Book Value:
  • Annual Revenue: $5.24 million
  • Price / Sales: 25.94
  • Book Value: $3.25 per share
  • Price / Book: 1.63
Profitability:
  • EBIDTA: ($19,530,000.00)
  • Net Margins: -235.47%
  • Return on Equity: -18.60%
  • Return on Assets: -17.16%
Debt:
  • Current Ratio: 17.05%
  • Quick Ratio: 17.04%
Misc:
  • Average Volume: 6,825 shs.
  • Beta: 0.61
  • Short Ratio: 0.64
 

Frequently Asked Questions for Evogene Ltd (NYSE:EVGN)

What is Evogene Ltd's stock symbol?

Evogene Ltd trades on the New York Stock Exchange (NYSE) under the ticker symbol "EVGN."

How were Evogene Ltd's earnings last quarter?

Evogene Ltd (NYSE:EVGN) issued its earnings results on Wednesday, May, 17th. The company reported ($0.19) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.18) by $0.01. The firm earned $0.72 million during the quarter. Evogene Ltd had a negative return on equity of 18.60% and a negative net margin of 235.47%. View Evogene Ltd's Earnings History.

Where is Evogene Ltd's stock going? Where will Evogene Ltd's stock price be in 2017?

1 equities research analysts have issued 1 year target prices for Evogene Ltd's stock. Their forecasts range from $10.00 to $10.00. On average, they expect Evogene Ltd's stock price to reach $10.00 in the next year. View Analyst Ratings for Evogene Ltd.

Who are some of Evogene Ltd's key competitors?

Who owns Evogene Ltd stock?

Evogene Ltd's stock is owned by a variety of of institutional and retail investors. Top institutional investors include UBS Group AG (4.13%), Bank of America Corp DE (3.28%), Goldman Sachs Group Inc. (2.36%), Clal Insurance Enterprises Holdings Ltd (2.35%), Vanguard Group Inc. (1.64%) and Canada Pension Plan Investment Board (1.10%). View Institutional Ownership Trends for Evogene Ltd.

Who sold Evogene Ltd stock? Who is selling Evogene Ltd stock?

Evogene Ltd's stock was sold by a variety of institutional investors in the last quarter, including Eidelman Virant Capital and Stockman Wealth Management Inc.. View Insider Buying and Selling for Evogene Ltd.

Who bought Evogene Ltd stock? Who is buying Evogene Ltd stock?

Evogene Ltd's stock was purchased by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., UBS Group AG, JPMorgan Chase & Co., Bank of America Corp DE, Jane Street Group LLC and Vanguard Group Inc.. View Insider Buying and Selling for Evogene Ltd.

How do I buy Evogene Ltd stock?

Shares of Evogene Ltd can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Evogene Ltd stock cost?

One share of Evogene Ltd stock can currently be purchased for approximately $5.30.

Analyst Ratings

Consensus Ratings for Evogene Ltd (NYSE:EVGN) (?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $10.00 (88.51% upside)

Analysts' Ratings History for Evogene Ltd (NYSE:EVGN)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
8/17/2016Credit Suisse Group AGLower Price TargetOutperform$19.00 -> $10.00N/AView Rating Details
11/19/2015Piper Jaffray CompaniesLower Price TargetNeutral$12.00 -> $8.00N/AView Rating Details
(Data available from 5/27/2015 forward)

Earnings

Earnings History for Evogene Ltd (NYSE:EVGN)
Earnings by Quarter for Evogene Ltd (NYSE:EVGN)
Earnings History by Quarter for Evogene Ltd (NYSE:EVGN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/17/20173/31/2017($0.18)($0.19)$0.72 millionViewN/AView Earnings Details
2/27/2017Q4($0.18)($0.26)$1.18 millionViewListenView Earnings Details
11/21/2016Q3($0.07)($0.20)$1.54 millionViewN/AView Earnings Details
8/11/2016Q2($0.11)($0.18)$5.36 million$3.82 millionViewListenView Earnings Details
5/19/2016Q1($0.11)($0.13)$2.70 million$2.00 millionViewListenView Earnings Details
3/1/2016Q415($0.17)($0.22)$3.90 million$2.46 millionViewN/AView Earnings Details
11/18/2015Q315($0.15)($0.13)$3.50 million$3.31 millionViewListenView Earnings Details
8/5/2015Q215($0.19)($0.20)$4.40 million$2.66 millionViewN/AView Earnings Details
5/19/2015Q115($0.20)($0.13)$3.65 million$2.70 millionViewListenView Earnings Details
2/26/2015Q4($0.12)($0.19)$3.64 millionViewN/AView Earnings Details
11/10/2014Q314($0.10)($0.17)$4.20 million$3.16 millionViewN/AView Earnings Details
8/20/2014Q214($0.11)($0.13)$4.77 million$3.85 millionViewN/AView Earnings Details
5/7/2014Q1 14($0.13)($0.09)$5.40 million$3.86 millionViewN/AView Earnings Details
3/19/2014Q413($0.08)($0.20)$4.95 million$4.41 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Evogene Ltd (NYSE:EVGN)
Current Year EPS Consensus Estimate: $-0.6600 EPS
Next Year EPS Consensus Estimate: $-0.1500 EPS

Dividends

Dividend History for Evogene Ltd (NYSE:EVGN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Evogene Ltd (NYSE:EVGN)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for Evogene Ltd (NYSE:EVGN)
Latest Headlines for Evogene Ltd (NYSE:EVGN)
Source:
DateHeadline
americanbankingnews.com logo Brokerages Expect Evogene Ltd (EVGN) to Post -$0.17 Earnings Per Share
www.americanbankingnews.com - May 18 at 10:26 AM
americanbankingnews.com logoEvogene Ltd (EVGN) Announces Quarterly Earnings Results, Misses Estimates By $0.01 EPS
www.americanbankingnews.com - May 18 at 10:26 AM
feeds.benzinga.com logoEvogene Reports First Quarter 2017 Financial Results
feeds.benzinga.com - May 17 at 8:12 AM
americanbankingnews.com logoEvogene (EVGN) Receives Daily News Impact Score of 0.17
www.americanbankingnews.com - May 4 at 7:01 PM
finance.yahoo.com logoEvogene Files Annual Report for the Year Ended December 31, 2016
finance.yahoo.com - May 4 at 11:56 AM
americanbankingnews.com logoEvogene (EVGN) Earning Somewhat Negative Press Coverage, Analysis Finds
www.americanbankingnews.com - May 1 at 10:19 AM
americanbankingnews.com logoEvogene Ltd (EVGN) Expected to Post Earnings of -$0.18 Per Share
www.americanbankingnews.com - April 27 at 7:08 PM
americanbankingnews.com logoFavorable News Coverage Extremely Likely to Affect Evogene (EVGN) Share Price
www.americanbankingnews.com - April 27 at 10:32 AM
finance.yahoo.com logoEvogene Financial Results for the First Quarter of 2017 Earnings Announcement Schedule
finance.yahoo.com - April 26 at 10:37 PM
americanbankingnews.com logoEvogene (EVGN) Given Media Impact Score of -0.10
www.americanbankingnews.com - April 24 at 1:26 PM
americanbankingnews.com logoEvogene (EVGN) Earning Somewhat Negative Media Coverage, Analysis Shows
www.americanbankingnews.com - April 21 at 1:23 PM
americanbankingnews.com logoEvogene (EVGN) Earns Daily Media Impact Score of 0.04
www.americanbankingnews.com - April 14 at 1:26 PM
americanbankingnews.com logoZacks: Brokerages Anticipate Evogene Ltd (EVGN) Will Announce Earnings of -$0.18 Per Share
www.americanbankingnews.com - April 6 at 5:19 PM
americanbankingnews.com logoZacks: Brokerages Anticipate Evogene Ltd (EVGN) Will Announce Earnings of -$0.18 Per Share
www.americanbankingnews.com - April 6 at 5:19 PM
americanbankingnews.com logoEvogene Ltd (EVGN) Short Interest Down 64.9% in March
www.americanbankingnews.com - April 6 at 1:28 PM
feeds.benzinga.com logoEvogene to Present Innovative Approach for Improving Cannabis for Medical Needs at CannaTech Summit
feeds.benzinga.com - March 7 at 7:28 AM
finance.yahoo.com logoEvogene Reports Fourth Quarter and Full Year 2016 Financial Results
finance.yahoo.com - February 27 at 7:24 PM
seekingalpha.com logoEvogene's (EVGN) CEO Ofer Haviv on Q4 2016 Results - Earnings Call Transcript
seekingalpha.com - February 27 at 7:24 PM
globenewswire.com logoEvogene and ICL Innovation Sign Collaboration for Development of Crop Enhancers
globenewswire.com - February 14 at 6:04 PM
finance.yahoo.com logoEvogene Fourth Quarter and Full Year 2016 Earnings Announcement Schedule
finance.yahoo.com - February 13 at 8:58 AM
streetinsider.com logoEvogene (EVGN) to Move from NYSE to NASDAQ
www.streetinsider.com - December 20 at 6:40 PM
us.rd.yahoo.com logo4:33 pm Evogene to transfer its stock exchange listing to the NASDAQ Global Market from the New York Stock Exchange
us.rd.yahoo.com - December 20 at 10:10 AM
streetinsider.com logoEvogene (EVGN) Announces Positive Efficacy, Stability Results from Ag-Biologicals Program Field Trial
www.streetinsider.com - November 17 at 5:41 AM
finance.yahoo.com logoEvogene Announces Positive Field Trial Results in Ag-biologicals Program
finance.yahoo.com - November 16 at 8:11 AM
finance.yahoo.com logoEvogene Third Quarter 2016 Earnings Announcement Schedule
finance.yahoo.com - November 2 at 8:05 AM
streetinsider.com logoEvogene (EVGN), IMAmt Enter Insect-Resistant Cotton Seed R&D Collaboration
www.streetinsider.com - October 20 at 10:25 AM
finance.yahoo.com logoEvogene and IMAmt Sign Collaboration for Genomic Promoter Discovery and Validation in Cotton
finance.yahoo.com - October 19 at 5:19 PM
finance.yahoo.com logo11:45 am (Thinly-Traded) Evogene and Instituto Mato-grossense do Algodo announce collaboration for the discovery and validation of novel genomic promoters to support IMAmt's product development of insect-resistant cotton varieties
finance.yahoo.com - October 19 at 5:19 PM
finance.yahoo.com logoEvogene Announces Participation at the 18th Annual Rodman & Renshaw Global Investment Conference in New York City September 11-13th, 2016
finance.yahoo.com - September 1 at 4:50 PM
streetinsider.com logoCredit Suisse Cuts Price Target on Evogene (EVGN) to $10 Following 2Q
www.streetinsider.com - August 17 at 10:11 PM
finance.yahoo.com logoEvogene to Present at Crops and Chemicals 2016 Conference
finance.yahoo.com - July 13 at 7:00 AM

Social

Chart

Evogene Ltd (EVGN) Chart for Saturday, May, 27, 2017

This page was last updated on 5/27/2017 by MarketBeat.com Staff